This page is no longer being updated and remains online for informational and historical purposes only. The information is accurate as of the last page update.
For questions about page contents, contact the Communications Division.
Economics and business graduate Marc L. Preminger ’71 has been elected to the board of directors of Inhibitex, Inc., a biopharmaceutical company that develops and commercializes “first in field” antibody-based products for the treatment and prevention of staphylococcal and other bacterial and fungal infections.
After a 26-year career with Cigna Healthcare, Preminger retired in 2002 as its senior vice president and chief financial officer. In addition to his role as a director of Inhibitex, he will serve as chairman of the company’s audit committee.
He received a master’s in actuarial science from Georgia State University.